Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PerkinElmer's Oxford Immunotec Secures New Approval from U.S. FDA Expanding Instrumentation for Latent Tuberculosis Detection Workflow

Author: Charles Gross | March 23, 2023 08:06am
PerkinElmer's Oxford Immunotec Secures New Approval from U.S. FDA Expanding Instrumentation for Latent Tuberculosis Detection Workflow Additional instrumentation for cell isolation expands automation options for laboratories to access the clinically superior T-SPOT®.TB test

Posted In: PKI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist